Results 231 to 240 of about 6,418,846 (364)

The ACCEPTance of automation: refining circulating tumor cells enumeration for improved metastatic colorectal cancer prognosis

Molecular Oncology, EarlyView.
This study highlights the potential of automated enumeration using the ACCEPT software to refine circulating tumor cell (CTC) detection in metastatic colorectal cancer (mCRC). The automated method demonstrates improved accuracy and reduced variability compared to the manual approach.
Michela De Meo, Marco Siringo, Alessandro Vici, Ann Zeuner, Orietta Gandini, Paola Gazzaniga, Chiara Nicolazzo   +6 more
wiley   +1 more source

THE EXCISION OF A TUMOR FROM THE BRAIN [PDF]

, 1885
Rickman J. Godlee, Hughes Bennett
openalex   +1 more source

Macrophages and Metabolism in the Tumor Microenvironment.

Cell Metabolism, 2019
I. Vitale, G. Manic, L. Coussens, G. Kroemer, L. Galluzzi   +4 more
semanticscholar   +1 more source

Exosomal non-coding RNAs: mediators of crosstalk between cancer and cancer stem cells. [PDF]

Cell Death Discov
Wang S, Shu J, Wang N, He Z.
europepmc   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source

TUMORS IN CEREBELLOPONTINE ANGLE [PDF]

, 1921
L. Muskens
openalex   +1 more source

Author Correction: Developing a prognosis and chemotherapy evaluating model for colon adenocarcinoma based on mitotic catastrophe-related genes

Scientific Reports
Yinglei Liu, Yamin Zhao, Siming Zhang, Shen Rong, Songnian He, Liqi Hua, Xingdan Wang, Hongjian Chen   +7 more
doaj   +1 more source

Anti-tumor vaccine efficacy depends on adjuvant type and associates with induced IgG subclass and glycosylation profiles. [PDF]

Exp Hematol Oncol
Lehrian S, Wasynczuk A, Petry J, Guderian M, Nouta J, Buhre JS, Lunding HB, Köcher P, Schumacher HF, Dühring L, Kurwahn K, Manzhula K, Manz R, Bartsch YC, Wuhrer M, Ehlers M.   +15 more
europepmc   +1 more source

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Molecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié, Davod R. Shah, Eliane E. S. Brechbühl, Michael McNicholas, Zhaoyang Xu, John H. Stockley, Laura Morcom, Diana Gold Diaz, Gemma C. Girdler, Rachel V. Seear, Gabriel Balmus, Rajiv R. Ratan, Harry Bulstrode, James A. Nathan, Manav Pathania, Kevin M. Brindle, David H. Rowitch   +16 more
wiley   +1 more source

Macrophage Diversity Enhances Tumor Progression and Metastasis

Cell, 2010
Binzhi Qian, J. Pollard
semanticscholar   +1 more source